4.2 Article

CD59 Underlines the Antiatherosclerotic Effects of C-Phycocyanin on Mice

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Magnolol attenuates neointima formation by inducing cell cycle arrest via inhibition of ERK1/2 and NF-κB activation in vascular smooth muscle cells

Rajendra Karki et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)

Article Plant Sciences

Protective effect of a Phyllanthus orbicularis aqueous extract against UVB light in human cells

Marioly Vernhes et al.

PHARMACEUTICAL BIOLOGY (2013)

Editorial Material Cardiac & Cardiovascular Systems

The Pleiotropic Effects of Statins in the Prevention of Atherosclerosis

Wei Kong et al.

CARDIOVASCULAR DRUGS AND THERAPY (2012)

Article Multidisciplinary Sciences

Humanin, a Cytoprotective Peptide, Is Expressed in Carotid Artherosclerotic Plaques in Humans

David G. Zacharias et al.

PLOS ONE (2012)

Article Cell Biology

The effects of CD59 gene as a target gene on breast cancer cells

Bing Li et al.

CELLULAR IMMUNOLOGY (2011)

Article Biochemistry & Molecular Biology

Apoptotic mechanism of MCF-7 breast cells in vivo and in vitro induced by photodynamic therapy with C-phycocyanin

Bing Li et al.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2010)

Article Hematology

Generation and phenotyping of mCd59a and mCd59b double-knockout mice

Xuebin Qin et al.

AMERICAN JOURNAL OF HEMATOLOGY (2009)

Article Biochemistry & Molecular Biology

Molecular immune mechanism of C-phycocyanin from Spirulina platensis induces apoptosis in HeLa cells in vitro

B Li et al.

BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2006)

Article Medicine, Research & Experimental

Effects of CD59 on antitumoral activities of phycocyanin from Spirulina platensis

B Li et al.

BIOMEDICINE & PHARMACOTHERAPY (2005)

Article Immunology

CD59a is the primary regulator of membrane attack complex assembly in the mouse

S Baalasubramanian et al.

JOURNAL OF IMMUNOLOGY (2004)

Review Pharmacology & Pharmacy

Complement and complement regulatory proteins as potential molecular targets for vascular diseases

J Acosta et al.

CURRENT PHARMACEUTICAL DESIGN (2004)